Prelude Capital Management, LLC Medicinova Inc Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$4.81 - $8.74 $146,705 - $266,570
-30,500 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$5.03 - $6.31 $153,415 - $192,455
30,500 New
30,500 $160,000

Others Institutions Holding MNOV

# of Institutions
34
Shares Held
4.69M
Call Options Held
7.2K
Put Options Held
3.8K
View Full List

About MEDICINOVA INC

MNOV Quotes by TradingView
  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $88.3M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email